These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 9764778

  • 1. Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.
    Diaz-Guerra TM, Martinez-Suarez JV, Laguna F, Valencia E, Rodriguez-Tudela JL.
    AIDS; 1998 Sep 10; 12(13):1601-10. PubMed ID: 9764778
    [Abstract] [Full Text] [Related]

  • 2. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F, Arzeni D, Del Prete MS, Sinicco A, Falconi Di Francesco L, Pasticci MB, Lamura L, Nuzzo MM, Burzacchini F, Coppola S, Chiodo F, Scalise G.
    J Antimicrob Chemother; 1998 May 10; 41(5):541-8. PubMed ID: 9630407
    [Abstract] [Full Text] [Related]

  • 3. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M, López-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF.
    J Clin Microbiol; 2002 Sep 10; 40(9):3135-9. PubMed ID: 12202543
    [Abstract] [Full Text] [Related]

  • 4. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
    Martínez M, López-Ribot JL, Kirkpatrick WR, Bachmann SP, Perea S, Ruesga MT, Patterson TF.
    J Antimicrob Chemother; 2002 Mar 10; 49(3):515-24. PubMed ID: 11864952
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH, Samaranayake LP, Tsang PC, Wong KH, Yeung KW.
    J Oral Pathol Med; 2001 Jul 10; 30(6):336-46. PubMed ID: 11459319
    [Abstract] [Full Text] [Related]

  • 6. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    White TC, Pfaller MA, Rinaldi MG, Smith J, Redding SW.
    Oral Dis; 1997 May 10; 3 Suppl 1():S102-9. PubMed ID: 9456667
    [Abstract] [Full Text] [Related]

  • 7. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.
    AIDS; 1994 Jul 10; 8(7):945-50. PubMed ID: 7946104
    [Abstract] [Full Text] [Related]

  • 8. Genetic dissimilarity of two fluconazole-resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient.
    Berenguer J, Diaz-Guerra TM, Ruiz-Diez B, Bernaldo de Quiros JC, Rodriguez-Tudela JL, Martinez-Suarez JV.
    J Clin Microbiol; 1996 Jun 10; 34(6):1542-5. PubMed ID: 8735114
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    Tumbarello M, Caldarola G, Tacconelli E, Morace G, Posteraro B, Cauda R, Ortona L.
    J Antimicrob Chemother; 1996 Oct 10; 38(4):691-9. PubMed ID: 8937963
    [Abstract] [Full Text] [Related]

  • 10. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S, Hofmann H.
    Mycoses; 1997 Oct 10; 40 Suppl 1():56-63. PubMed ID: 9417515
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
    Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M.
    J Clin Microbiol; 1994 Sep 10; 32(9):2092-8. PubMed ID: 7814530
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
    Chryssanthou E, Torssander J, Petrini B.
    Scand J Infect Dis; 1995 Sep 10; 27(4):391-5. PubMed ID: 8658076
    [Abstract] [Full Text] [Related]

  • 18. Comparison of four molecular typing methods for evaluating genetic diversity among Candida albicans isolates from human immunodeficiency virus-positive patients with oral candidiasis.
    Díaz-Guerra TM, Martínez-Suárez JV, Laguna F, Rodríguez-Tudela JL.
    J Clin Microbiol; 1997 Apr 10; 35(4):856-61. PubMed ID: 9157142
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S.
    Lett Appl Microbiol; 2018 Oct 10; 67(4):392-399. PubMed ID: 30019443
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.